Pricing
Sign up

Aerovance

Go to market map
Similar Companies
+3 more
Sign in for full access
Short description
Aerovance is a biotech company focused on developing and commercializing medicines for respiratory and allergic diseases.
Description
Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing breakthrough medicines for respiratory and allergic diseases. The company maintains a solid intellectual property position with its strong portfolio of novel therapeutic candidates now in clinical development and several pre-clinical programs. The two lead products are human recombinant proteins: Aerovantâ„¢, an IL-4 and -13 receptor antagonist which is in Phase IIa studies for asthma and Aerodermâ„¢, a PEGylated IL-4 and IL-13 receptor antagonist in pre-clinical studies for eczema.
Total funding
$$43214321
Sign in for full access
Location
Berkeley, California, United States, North America
Founded on
January 1, 2004
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noaccessforu, No Way, Absolutely Noaccess, Blurry Noaccess, Nopepepe, Noaccess, Noaccessforu, Noaccessforu, Absolutely Noaccess, Noaccess
Sign in for full access
Founders
Wolf D. Busse